JP Morgan Chase’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.1M Sell
222,714
-134,788
-38% -$11.9M ﹤0.01% 2063
2025
Q4
$28.7M Buy
357,502
+140,108
+64% +$11.7M ﹤0.01% 1749
2025
Q3
$21.2M Buy
217,394
+39,527
+22% +$3.18M ﹤0.01% 2048
2025
Q2
$12.4M Buy
177,867
+7,856
+5% +$448K ﹤0.01% 2361
2025
Q1
$8.44M Sell
170,011
-19,557
-10% -$1.24M ﹤0.01% 2695
2024
Q4
$13.2M Buy
189,568
+10,645
+6% +$884K ﹤0.01% 2434
2024
Q3
$18.8M Sell
178,923
-49,921
-22% -$5.84M ﹤0.01% 2047
2024
Q2
$32.5M Sell
228,844
-237,791
-51% -$27.4M ﹤0.01% 1502
2024
Q1
$52M Sell
466,635
-97,494
-17% -$11.6M ﹤0.01% 1261
2023
Q4
$73.2M Buy
564,129
+220,994
+64% +$30.5M 0.01% 1038
2023
Q3
$55.9M Buy
343,135
+168,222
+96% +$29.6M 0.01% 1063
2023
Q2
$32.1M Buy
174,913
+66,753
+62% +$9.61M ﹤0.01% 1354
2023
Q1
$14.4M Sell
108,160
-729
-0.7% -$85.6K ﹤0.01% 1940
2022
Q4
$8.64M Sell
108,889
-6,268
-5% -$442K ﹤0.01% 2387
2022
Q3
$6.97M Buy
115,157
+49,849
+76% +$3.22M ﹤0.01% 2446
2022
Q2
$3.58M Buy
65,308
+9,365
+17% +$543K ﹤0.01% 3075
2022
Q1
$4.23M Buy
55,943
+11,111
+25% +$759K ﹤0.01% 3148
2021
Q4
$3.34M Sell
44,832
-39,264
-47% -$2.33M ﹤0.01% 3397
2021
Q3
$3.96M Sell
84,096
-16,245
-16% -$707K ﹤0.01% 3231
2021
Q2
$4.06M Sell
100,341
-35,488
-26% -$1.47M ﹤0.01% 3240
2021
Q1
$5.58M Buy
135,829
+84,937
+167% +$3.17M ﹤0.01% 2873
2020
Q4
$1.48M Buy
50,892
+12,177
+31% +$315K ﹤0.01% 3703
2020
Q3
$854K Sell
38,715
-45,219
-54% -$1.15M ﹤0.01% 3728
2020
Q2
$2.34M Sell
83,934
-5,413
-6% -$132K ﹤0.01% 3008
2020
Q1
$1.64M Sell
89,347
-35,969
-29% -$836K ﹤0.01% 3100
2019
Q4
$3.02M Sell
125,316
-2,358
-2% -$49.7K ﹤0.01% 3085
2019
Q3
$2.18M Sell
127,674
-34,278
-21% -$548K ﹤0.01% 3367
2019
Q2
$2.43M Sell
161,952
-19,515
-11% -$349K ﹤0.01% 3247
2019
Q1
$3.65M Buy
181,467
+170,055
+1,490% +$3.45M ﹤0.01% 2856
2018
Q4
$203K Sell
11,412
-34,711
-75% -$617K ﹤0.01% 4595
2018
Q3
$907K Sell
46,123
-193,414
-81% -$3.98M ﹤0.01% 3984
2018
Q2
$4.74M Buy
239,537
+31,289
+15% +$688K ﹤0.01% 2724
2018
Q1
$5.12M Buy
208,248
+158,065
+315% +$4.15M ﹤0.01% 2555
2017
Q4
$1.44M Buy
50,183
+49,619
+8,798% +$1.56M ﹤0.01% 3516
2017
Q3
$15K Hold
564
﹤0.01% 4656
2017
Q2
$12K Sell
564
-19,404
-97% -$410K ﹤0.01% 4623
2017
Q1
$376K Sell
19,968
-30,284
-60% -$477K ﹤0.01% 3832
2016
Q4
$731K Buy
50,252
+48,977
+3,841% +$667K ﹤0.01% 3585
2016
Q3
$17K Sell
1,275
-2
-0.2% -$23 ﹤0.01% 4220
2016
Q2
$14K Hold
1,277
﹤0.01% 4285
2016
Q1
$14K Hold
1,277
﹤0.01% 4168
2015
Q4
$13K Buy
+1,277
New +$13.6K ﹤0.01% 4155
2014
Q1
Sell
-14,500
Closed -$142K 3553
2013
Q4
$142K Sell
14,500
-11,918
-45% -$108K ﹤0.01% 3863
2013
Q3
$224K Buy
26,418
+15,722
+147% +$127K ﹤0.01% 4001
2013
Q2
$77K Buy
+10,696
New +$62.1K ﹤0.01% 4206

Other funds holding ACLS

JP Morgan Chase's ACLS Position: Q1 2026 in Review

JP Morgan Chase reduced its Axcelis (ACLS) stake by 38% in Q1 2026, selling an estimated $11.9M and leaving 222,714 shares worth $20.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2063.

JP Morgan Chase first reported a position in ACLS in Q2 2013 and has held it in 45 quarters since. The position peaked at $73.2M in Q4 2023. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • JP Morgan Chase held 222,714 shares of Axcelis worth $20.1M as of Q1 2026.
  • JP Morgan Chase sold 134,788 Axcelis shares in Q1 2026, an estimated $11.9M.
  • Axcelis made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2063 holding.
  • JP Morgan Chase first reported a position in Axcelis in Q2 2013 and has held it in 45 quarters since.
  • JP Morgan Chase's Axcelis position peaked at $73.2M in Q4 2023.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.